ICL Third Quarter 2026 Earnings Call - International - EVOGENE LTD

Financial Performance:

• Third-quarter 2026 sales reached $1.9 billion, a 3% year-over-year increase.
• Adjusted EBITDA stood at $402 million, up 1% annually, despite record raw material and logistics costs.
• Gross margin improved 30 basis points to 32.9%, the highest rate since Q4 2024.
• Adjusted net income rose 2% to $126 million, translating to $0.10 per share.
• Operating cash flow was $256 million, while free cash flow was $66 million.
• Net debt to adjusted EBITDA ratio remained stable at 1.5x.
• Total dividends paid were $63 million, resulting in a 12-month dividend yield of 4.1%.

Guidance and Future Outlook:

• Reiterated 2026 consolidated EBITDA guidance of $1.5 billion to $1.7 billion, with a target to exceed the midpoint.
• Potash sales volume guidance remains 4.5 to 4.7 million metric tons.
• Expected annual adjusted tax rate is approximately 30%.
• 2027 outlook is positive; the company expects to enter the year from a position of strength with constructive industry fundamentals.
• Full-year 2026 Q4 may face headwinds from higher sulfur inventory costs, but purchase price pressures are easing, suggesting 2027 will be significantly better.
• "Elevate" cost transformation program aims for >$150 million annual EBITDA improvement by end-2027 and >$350 million by end-2028.

Business Segments and Product Lines:

• Industrial Products: Sales up 18% to $347 million; EBITDA surged nearly 50% to $100 million driven by higher bromine prices and demand in electronics/construction.
• Potash: Sales up 4% to $469 million; EBITDA declined ~7% due to energy/logistics costs and currency headwinds despite a 5% price increase.
• Phosphate Solutions: Sales $589 million with 20% EBITDA margin; specialty industrial phosphates grew on EV battery demand, while food phosphates saw slight declines. Production optimized to manage record sulfur prices.
• Growing Solutions: Sales $538 million; EBITDA $44 million. Navigated soft demand in Brazil and European affordability issues through pricing discipline and mix optimization.
• Strategic Restructuring: New organizational structure effective January 1, 2027, creating four segments: Nutrition Solutions, Industrial Solutions, Essential Minerals (Potash + Commodity Phosphates), and Growing Solutions.

Market and Competitive Landscape:

• Potash: Market stabilizing; prices remain affordable vs. nitrogen/phosphate, supporting demand. China replenishing inventory; contract negotiations ongoing.
• Phosphates: Sulfur spot prices rose 220% annually in Q3 but declined 12% in October; purchase price benefits expected to flow into Q1 2027 results.
• Agriculture: Grain prices improved in the US, enhancing farmer sentiment, though affordability remains a constraint in Europe and Brazil.
• Industrial: Bromine prices rebounded in October to Q1 levels, supporting future quarters; demand robust in electronics and oil/gas.
• Logistics: Ocean freight rates elevated (up 24% YoY) but expected to remain manageable.

Risks and Challenges:

• Cost Pressures: Record high raw material costs (specifically sulfur), energy, and freight/logistics expenses impacted margins.
• Currency Fluctuations: Exchange rate headwinds (though USD strengthened slightly vs. Shekel in Q3, it remains a risk for Israeli operations).
• Regional Weakness: Soft market conditions and delayed purchasing in Brazil; weak farmer affordability in Europe.
• Sulfur Inventory Lag: Q4 P&L will reflect higher sulfur costs due to existing inventory, even as current purchase prices decline.

Management Commentary and Tone:

• Tone was confident and resilient, emphasizing proactive management of controllable factors despite challenging macro conditions.
• Management highlighted the strength of their diversified portfolio in mitigating sector-specific downturns.
• Confident in achieving the 2027 "Elevate" cost savings targets and entering the new year with a strong balance sheet.
• Emphasized long-term commitment to Brazil and strategic positioning for 2027 growth.

Analyst Questions and Answers:

• Cost Savings Confidence: Management expressed high confidence in achieving the $150 million annualized EBITDA improvement from the "Elevate" program by end-2027, with benefits ramping up from Q4 2026.
• 2027 Market Outlook: Expectations for 2027 include stabilized potash demand, growth in phosphate fertilizer demand (due to farmers returning after skipping 2026), and sustained industrial demand.
• Q4 Potash Margins: No dramatic change expected in Q4 potash volumes or margins relative to Q3, with constructive fundamentals supporting the segment.
• 2026 Guidance Risks: Primary downside risk for Q4 is sulfur inventory costs; upside potential relies on bromine prices and improved sulfur purchase prices flowing into the P&L in 2027.

Other Key Points:

• Acquired Barter is being integrated, with cross-selling of functional ingredients in bakery and confectionery sectors already underway.
• Focus on biostimulants to enhance fertilizer efficiency in the growing solutions segment.
• Leverage of AI infrastructure and semiconductor demand for industrial phosphate products.
• Capital allocation continues with a 50% payout of adjusted net income to shareholders.